Related Experiment Videos
Detecting depression in Chinese stroke patients: a pilot study comparing four screening instruments
Wai Kwong Tang1, Gabor S Ungvari, Helen F K Chiu
1Chinese University of Hong Kong, Shatin Hospital, Department of Psychiatry, Hong Kong, China. tangwk@cuhk.edu.hk
International Journal of Psychiatry in Medicine
|September 25, 2004
Summary
The Hospital Anxiety and Depression Scale (HADS) and Geriatric Depression Scale (GDS) effectively screen for depression in Chinese stroke survivors. The Visual Analogue Mood Scale (VAMS) was not suitable for this population.
Area of Science:
- Neuroscience
- Psychiatry
- Rehabilitation Medicine
Background:
- Post-stroke depression is a common complication affecting patient recovery and quality of life.
- Accurate screening for depression is crucial for timely intervention in stroke patients.
- Cultural specificity of screening tools is a significant consideration in diverse populations.
Purpose of the Study:
- To evaluate the suitability of different depression screening instruments for Chinese stroke patients.
- To compare the performance of the Visual Analogue Mood Scale (VAMS), Hospital Anxiety and Depression Scale (HADS), and Geriatric Depression Scale (GDS).
Main Methods:
- A sample of 60 Chinese first-ever stroke patients in a rehabilitation facility were assessed.
- Screening instruments included VAMS, HADS, and GDS; psychiatric diagnoses used SCID-DSM-III-R as a benchmark.
- Performance metrics included response rate, sensitivity, specificity, predictive values, and ROC curves.
Main Results:
- The VAMS demonstrated limited utility for detecting depression in this cohort.
- Both HADS and GDS showed satisfactory accuracy in identifying depression among Chinese stroke patients.
- Comparative analysis confirmed the efficacy of HADS and GDS over VAMS.
Conclusions:
- Depression screening tools are not universally applicable and exhibit cultural specificity.
- Established screening scales require validation in different cultural contexts before clinical use.
- HADS and GDS are recommended for screening depression in Chinese stroke patients, pending further validation.